Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease
Joseph Blommer, Toni L. Pitcher, Maja Mustapić, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 195-208
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
Suman Dutta, Simon Hornung, Hash Brown Taha, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 5, pp. 515-540
Open Access | Times Cited: 56
A Panorama of Extracellular Vesicle Applications: From Biomarker Detection to Therapeutics
S. Jerome Das, Christopher J. Lyon, Tony Hu
ACS Nano (2024) Vol. 18, Iss. 14, pp. 9784-9797
Open Access | Times Cited: 29
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Jessica R. Cohen, Annette Mathew, Kirk D. Dourvetakis, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 511-511
Open Access | Times Cited: 26
Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease
Francheska Delgado‐Peraza, Carlos Nogueras‐Ortiz, Anja Hviid Simonsen, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta‐Analysis
Mary Xylaki, A Chopra, Sandrina Weber, et al.
Movement Disorders (2023) Vol. 38, Iss. 9, pp. 1585-1597
Open Access | Times Cited: 23
Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis
Hash Brown Taha, Aleksander Bogoniewski
Journal of Neurology (2023) Vol. 271, Iss. 4, pp. 1680-1706
Open Access | Times Cited: 23
Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications
Akanksha Onkar, Fatima Khan, Anshika Goenka, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6709-6742
Closed Access | Times Cited: 10
Extracellular Vesicles as Mediators of Neuroinflammation in Intercellular and Inter-Organ Crosstalk
Andrea Cabrera‐Pastor
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7041-7041
Open Access | Times Cited: 10
Potential Exosome Biomarkers for Parkinson’s Disease Diagnosis: A Systematic Review and Meta-Analysis
Ka Young Kim, Ki Young Shin, Keun‐A Chang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5307-5307
Open Access | Times Cited: 9
Single‐extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron‐derived EVs
Carlos Nogueras‐Ortiz, Erden Eren, Pamela J. Yao, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 9
Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies
Mehrnoosh Bahadorani, Mahboobeh Nasiri, Kristen Dellinger, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7137-7164
Open Access | Times Cited: 8
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease
Charysse Vandendriessche, Dimitrios Kapogiannis, Roosmarijn E. Vandenbroucke
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114486-114486
Open Access | Times Cited: 30
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Nirosen Vijiaratnam, Thomas Foltynie
Brain (2023) Vol. 146, Iss. 12, pp. 4845-4869
Open Access | Times Cited: 17
Emerging Role of Extracellular Vesicles as Biomarkers in Neurodegenerative Diseases and Their Clinical and Therapeutic Potential in Central Nervous System Pathologies
Michele Malaguarnera, Andrea Cabrera‐Pastor
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10068-10068
Open Access | Times Cited: 6
Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
Lidan Hu, Wenmin Wang, Xiangjun Chen, et al.
Brain‐X (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Dual role of brain-derived extracellular vesicles in dementia-related neurodegenerative disorders: cargo of disease spreading signals and diagnostic-therapeutic molecules
Francesca Natale, Salvatore Fusco, Claudio Grassi
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics
Konstantinos Avgerinos, Roger J. Mullins, Michael Vreones, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3372-3372
Open Access | Times Cited: 22
Plasma versus serum for extracellular vesicle (EV) isolation: A duel for reproducibility and accuracy for CNS‐originating EVs biomarker analysis
Hash Brown Taha
Journal of Neuroscience Research (2023) Vol. 101, Iss. 11, pp. 1677-1686
Open Access | Times Cited: 15
METTL14 is decreased and regulates m6A modification of α‐synuclein in Parkinson's disease
Honghu He, Qinxin Zhang, Jiajia Liao, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 3, pp. 609-622
Closed Access | Times Cited: 14
Evaluation of α‐synuclein in CNS‐originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta‐analysis
Hash Brown Taha, Shomik S. Ati
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 12, pp. 3741-3755
Open Access | Times Cited: 14
Electrochemical detection of extracellular vesicles for early diagnosis: a focus on disease biomarker analysis
Jintao Zheng, Runzhi Zhou, Bing Wang, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2024) Vol. 5, Iss. 2, pp. 165-79
Open Access | Times Cited: 5
Refining the clinical diagnosis of Parkinson's disease
Eoin Mulroy, Roberto Erro, Kailash P. Bhatia, et al.
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106041-106041
Closed Access | Times Cited: 4
Mild cognitive impairment in Parkinson's disease: current view
K. A. Jellinger
Frontiers in Cognition (2024) Vol. 3
Open Access | Times Cited: 4
Exosomes: The endogenous nanomaterials packed with potential for diagnosis and treatment of neurologic disorders
Xuelin Tang, Yuxuan He, Jinchi Liu, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 239, pp. 113938-113938
Closed Access | Times Cited: 4
Biomarkers in Parkinson’s Disease
Sarah M. Brooker, Paulina González-Latapí
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 229-248
Closed Access
Page 1 - Next Page

Scroll to top